
NRIX
Healthcare · Biotechnology · $1.69B market cap
$15.48-0.12 (-0.8%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Nov 30, 2026
EPS trend, 90 days to now · +509.2% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 12, 2026 | Time not confirmed | -0.56 | 4.73 | +944.6% |
| Jul 9, 2026 | After the close | -0.73 | -0.81 | -11.0% |
| Apr 14, 2026 | Time not confirmed | -0.83 | -0.79 | +4.8% |
| Jan 28, 2026 | After the close | -0.92 | -0.82 | +10.9% |
| Oct 9, 2025 | After the close | -0.85 | -1.03 | -21.2% |
| Jul 9, 2025 | After the close | -0.74 | -0.52 | +29.7% |
| Apr 8, 2025 | After the close | -0.76 | -0.67 | +11.8% |
| Feb 13, 2025 | Before the open | -0.67 | -0.75 | -12.1% |
| Oct 11, 2024 | After the close | -0.68 | -0.67 | +1.5% |
| Jul 11, 2024 | After the close | -0.63 | -0.71 | -12.7% |
| Apr 10, 2024 | Before the open | -0.80 | -0.76 | +5.0% |
| Feb 15, 2024 | After the close | -0.50 | -0.77 | -54.0% |
| Oct 12, 2023 | After the close | -0.74 |
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and…
| -0.68 |
| +8.1% |
| Jul 13, 2023 | After the close | -0.57 | -0.45 | +21.1% |
| Apr 13, 2023 | After the close | -0.87 | -0.75 | +13.8% |
| Feb 9, 2023 | After the close | -0.79 | -0.87 | -10.1% |
| Oct 6, 2022 | After the close | -0.95 | -0.90 | +5.3% |
| Jul 7, 2022 | After the close | -0.99 | -1.01 | -2.0% |
| Apr 8, 2022 | After the close | -0.89 | -0.95 | -6.7% |
| Jan 27, 2022 | After the close | -0.69 | -0.85 | -23.2% |
| Oct 14, 2021 | After the close | -0.62 | -0.65 | -4.8% |
| Jul 13, 2021 | After the close | -0.56 | -0.60 | -7.1% |
| Apr 13, 2021 | After the close | -0.45 | -0.63 | -40.0% |
| Feb 16, 2021 | After the close | -0.54 | -0.51 | +5.6% |
| Oct 14, 2020 | After the close | -0.45 | -0.59 | -31.1% |
| Jul 24, 2020 | After the close | — | -1.09 | — |
| May 5, 2020 | Time not confirmed | — | -1.91 | — |